➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

MELOXICAM Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Meloxicam, and what generic alternatives are available?

Meloxicam is a drug marketed by Lupin Ltd, Novitium Pharma, Anda Repository, Apotex Inc, Aurobindo Pharma, Cipla, Cr Double Crane, Dr Reddys Labs Inc, Glenmark Generics, Heritage Pharma, Impax Labs Inc, Lupin Pharms, Mylan, Nostrum Labs Inc, Puracap Pharm, Roxane, Strides Pharma, Sun Pharm Inds Inc, Taro, Unichem, Yabao Pharm, Yung Shin Pharm, and Zydus Pharms Usa. and is included in twenty-four NDAs.

The generic ingredient in MELOXICAM is meloxicam. There are twenty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the meloxicam profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Meloxicam

A generic version of MELOXICAM was approved as meloxicam by CIPLA on July 19th, 2006.

  Get Started for $10

Drug patent expirations by year for MELOXICAM
Drug Prices for MELOXICAM

See drug prices for MELOXICAM

Drug Sales Revenue Trends for MELOXICAM

See drug sales revenues for MELOXICAM

Recent Clinical Trials for MELOXICAM

Identify potential brand extensions & 505(b)(2) entrants

Emory UniversityPhase 4
Rothman Institute OrthopaedicsPhase 3
Daewoong Pharmaceutical Co. LTD.Phase 1

See all MELOXICAM clinical trials

Pharmacology for MELOXICAM
Paragraph IV (Patent) Challenges for MELOXICAM
Tradename Dosage Ingredient NDA Submissiondate
VIVLODEX CAPSULE;ORAL meloxicam 207233 2017-01-09
MOBIC SUSPENSION;ORAL meloxicam 021530 2009-12-17

US Patents and Regulatory Information for MELOXICAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unichem MELOXICAM meloxicam TABLET;ORAL 077927-001 Dec 20, 2006 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Puracap Pharm MELOXICAM meloxicam TABLET;ORAL 077938-002 Jul 19, 2006 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Yung Shin Pharm MELOXICAM meloxicam TABLET;ORAL 077918-001 Dec 7, 2006 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Mylan MELOXICAM meloxicam TABLET;ORAL 077934-002 Jul 20, 2006 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Roxane MELOXICAM meloxicam TABLET;ORAL 077925-001 Jul 19, 2006 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Nostrum Labs Inc MELOXICAM meloxicam TABLET;ORAL 077920-001 Jul 19, 2006 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.